Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $705,919 (100.0% shares, 0.0% debt)

Holdings (34)

Menlo Therapeutics 21.4%
Value ($000) $150,742 Shares 4,011,236 Est. Cost $37.58 Unrealized
ASND Ascendis Pharma 20.1%
Value ($000) $141,711 Shares 2,166,832 Est. Cost $26.35 Unrealized
Biohaven Pharmaceutical Holding Company Ltd 7.5%
Value ($000) $52,796 Shares 2,049,545 Est. Cost $36.97 Unrealized
CDXS Codexis, Inc. 4.8%
Value ($000) $33,603 Shares 3,054,825 Est. Cost $3.85 Unrealized +148.4%
APLS Apellis Pharmaceuticals, Inc. 4.6%
Value ($000) $32,233 Shares 1,457,834 Est. Cost $14.72 Unrealized +33.5%
Verona Pharma Plc 4.2%
Value ($000) $29,859 Shares 1,492,951 Est. Cost $13.61 Unrealized
ACRS Aclaris Therapeutics 4.1%
Value ($000) $28,859 Shares 1,647,214 Est. Cost $19.11 Unrealized +10.9%
Homology Medicines, Inc. 3.1%
Value ($000) $21,687 Shares 1,159,742 Est. Cost $18.70 Unrealized
Nabriva Therapeutics Plc 2.9%
Value ($000) $20,493 Shares 4,074,190 Est. Cost $8.19 Unrealized
Amyris, Inc. 2.7%
Value ($000) $18,911 Shares 2,826,711 Est. Cost $3.20 Unrealized
Eiger BioPharmaceuticals 2.5%
Value ($000) $17,644 Shares 1,791,257 Est. Cost $16.42 Unrealized
Strongbridge Biopharma plc 2.4%
Value ($000) $16,975 Shares 1,918,132 Est. Cost $2.40 Unrealized
Kala Pharmaceuticals, Inc. 2.3%
Value ($000) $16,511 Shares 1,043,020 Est. Cost $22.84 Unrealized
Kadmon Holdings (KDMN) 2.0%
Value ($000) $14,167 Shares 3,333,333 Est. Cost $3.35 Unrealized
ARWR Arrowhead Pharmaceuticals Inc 1.9%
Value ($000) $13,699 Shares 1,900,000 Est. Cost $6.16 Unrealized 0.0%
Selecta Biosciences, Inc. 1.6%
Value ($000) $11,405 Shares 1,119,189 Est. Cost $19.86 Unrealized
Cymabay Therapeutics Inc 1.5%
Value ($000) $10,392 Shares 800,000 Est. Cost $12.99 Unrealized
Aimmune Therapeutics, Inc. 1.4%
Value ($000) $9,768 Shares 306,872 Est. Cost $10.99 Unrealized
Genocea Biosciences Inc 1.2%
Value ($000) $8,589 Shares 8,180,000 Est. Cost $1.05 Unrealized
Soleno Therapeutics, Inc. 1.0%
Value ($000) $7,313 Shares 4,033,534 Est. Cost $1.80 Unrealized
AUPH Aurinia Pharmaceuticals Inc. 0.9%
Value ($000) $6,297 Shares 1,213,290 Est. Cost $5.62 Unrealized -4.8%
ZLAB Zai Lab LTD 0.9%
Value ($000) $6,059 Shares 283,787 Est. Cost $27.00 Unrealized
Sierra Oncology, Inc 0.7%
Value ($000) $5,047 Shares 2,438,270 Est. Cost $1.55 Unrealized
RGNX Regenxbio Inc. 0.7%
Value ($000) $4,907 Shares 164,403 Est. Cost $12.80 Unrealized +127.4%
Foamix Pharmaceuticals Ltd. 0.6%
Value ($000) $4,386 Shares 855,000 Est. Cost $9.26 Unrealized
Zogenix, Inc. 0.6%
Value ($000) $4,205 Shares 105,000 Est. Cost $40.05 Unrealized
Agile Therapeutics, Inc. 0.6%
Value ($000) $3,891 Shares 1,513,975 Est. Cost $6.21 Unrealized
BioPharmX Corporation 0.5%
Value ($000) $3,726 Shares 16,128,515 Est. Cost $0.36 Unrealized
MDGL Madrigal Pharmaceuticals Inc 0.5%
Value ($000) $3,179 Shares 27,220 Est. Cost $123.44 Unrealized 0.0%
KALV KalVista Pharmaceuticals, Inc. 0.4%
Value ($000) $2,847 Shares 300,325 Est. Cost $7.13 Unrealized +46.9%
Trevena, Inc. 0.4%
Value ($000) $2,834 Shares 1,728,000 Est. Cost $7.67 Unrealized
Akari Therapeutics Plc 0.1%
Value ($000) $629 Shares 345,850 Est. Cost $14.00 Unrealized
Sunesis Pharmaceuticals, Inc. 0.1%
Value ($000) $532 Shares 195,474 Est. Cost $3.62 Unrealized
Soleno Therapeutics, Inc. 0.0%
Value ($000) $23 Shares 188,772 Est. Cost $0.14 Unrealized